Cook Islands Tech Reporter
SEE OTHER BRANDS

Fresh news on science and technology in the Cook Islands

Cook Islands Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cook Islands Tech Reporter.

Press releases published on August 12, 2025

Independent Stanford Research Shows SchoolAI Drives Consistent and Deep Teacher Adoption of AI Tools
RemoFirst Soars Into the Top 100 of Inc. 5000’s Fastest-Growing Companies List
SUSE als führendes Unternehmen im Gartner® Magic Quadrant™ für Container-Management 2025 ausgezeichnet
SUSE reconnu comme leader dans le 2025 Gartner® Magic Quadrant™ for Container Management
Thrive 新領導層上任以持續拓展亞太區業務
Philips Home Access to showcase smart lock and video doorbell innovations at Ace Hardware Fall Convention 2025
Waabi Hires Industry Veteran, Lior Ron, as Chief Operating Officer, Positioning the Company for Rapid Commercial Growth
360 Privacy Ranks No. 364 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
fullthrottle.a️i® Recognized on the Inc. 5000 List for the Third Consecutive Year in a Row Amid Record Growth
LYT Named to Prestigious 2025 Inc. 5000 List of Fastest-Growing Private Companies; Ranked in Top 10% of All Companies
SignWell Completes Fourth Consecutive SOC 2 Type II Certification
AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
Integer Technologies Ranks No. 95 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
Mvix to Assist with FEMA’s Next Generation Warning System Grant Program (NGWSGP)
TerraMaster lancia l’F2-425 2-Bay NAS: Benchmark delle prestazioni Intel x86
Alarum to Release Second Quarter 2025 Results  on August 28, 2025
Aditude Ranks No. 251 on the 2025 Inc. 5000 List with 1550% Growth
Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
Rpharmy’s Rhazdrugs Wins Silver Stevie Award for Technology Excellence in Healthcare
Senti Bio Participates in Virtual Investor “What This Means” Segment Discussing The Phase 2 Dose and Schedule Selection for SENTI-202 in its Clinical Trial for Acute Myeloid Leukemia

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions